COVID-19
Fraud and Abuse Denied EI Claims for the Unvaccinated

From the Frontier Centre for Public Policy
By Lee Harding
Should Canadians who lost their jobs over vaccine mandates have been denied Employment Insurance? Certified financial examiner Lex Acker says no, and that $12.9 billion of EI should have been paid out.
Acker presented his findings June 2 in Regina at the National Citizens Inquiry on COVID-19. His wife, a Nanaimo, BC nurse not named in his testimony, lost her job due to non-compliance with vaccine mandates.
Late in 2021, federal Employment Minister Carla Qualtrough announced that unvaccinated employees would be denied Employment Insurance (EI), but Acker’s wife applied just the same.
According to Acker, a subsequent appeal included a reference to a Supreme Court ruling in which medical coercion was found to equate to assault. An EI agent admitted to Acker that the appeal “got everyone’s attention” at the federal agency but was denied anyway.
Acker applied for all documentation related to the decision and received 1200 pages. Included was a 12-page document entitled BE Memo 2021-10, which directed EI agents on how to administer claims for the unvaccinated.
“The memorandum is not linked to any legislative or regulatory amendments,” the memo explained.
Given the minister’s announcement all such cases would be denied, the memo seems little more than pretense, despite its apparent departure from normal practice.
The memo mandated three requirements to establish a finding of misconduct for an applicant.
- “The employer has adopted and communicated a clear mandatory vaccination policy to all affected employees;”
- “The employees are aware that the failure to comply with the policy would cause a loss of employment;”
- “The application of the policy to the employee is reasonable within the workplace context.”
According to the response to Acker’s wife, which Acker included in a sworn affadavit, the EI agent on the case asked the Vancouver Island Health Authority for the appropriate documentation. The Ei agent noted such documentation was never received, yet denied the claim with the words, “Misconduct proven.”
The EI memo explicitly stated that claimants could still bring Charter arguments forward. Then again, the memo also validated an “employer’s professional expectations,” an apparent veiled reference to vaccination. The memo explained that it was not enough for applicants to say they suffered “discrimination.” Instead, ”the client must be able to demonstrate how they were discriminated against and on what grounds.”
It’s not clear how that would happen if the minister directed all applications to be refused.
Remarkably, the EI agent in Acker’s case acknowledged stated arguments against the safety and efficacy of the vaccines, but said assessing such judgments was beyond the scope of an EI agent, as were “Charter Rights violation arguments.” The agent told Acker to turn to “the Courts, Human Rights Commission, Labour Standards” instead.
The memo said that claimants citing a religious exemption had to show “a clear link” with proof “that the client’s religion is preventing them from being vaccinated” but not use a Bible or Qu’ran.
“[T]he interpretation of sacred texts by the client themselves must not be seen as a particular practice required by their faith,” the memo explained.
The employer also had wide discretion on what medical exemptions to accept.
“In some cases, the employer can refuse to accept a medical certificate because it does not meet the conditions of the employer’s mandatory vaccination policy,” the memo explained.
“However, the client could have another credible medical reason, such as a mental illness or other condition justifying their refusal.”
If the suggestion mental illness could have contributed to vaccine refusals isn’t biased, then what is?
On Substack, Acker estimated a 9.7% termination rate from positions in B.C. Health, based on vacant positions. His analysis of employer pension contributions suggested similar termination rates of 8.6% to 11.5%.
Acker extrapolated these vaccination and employment rates, and the average EI payout of $26,000, to estimate that unvaccinated Canadians forfeited $12.9 billion in EI claims.
A lay perusal of the criminal code by the analyst suggested potential avenues for litigation, such as fraud, breach of trust by a public officer, and disobeying a statute. Tort for misfeasance in public office might also be a civil remedy.
Acker said the EI rejections were due to systemic fraud and abuse, and he has made a good case. Canadians bemoaning the failed government response to the pandemic have yet another reason to demand accountability.
Lee Harding is a Research Fellow at the Frontier Centre for Public Policy
COVID-19
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’

From LifeSiteNews
The director of National Intelligence revealed gain-of-function ties to US funding, which could indicate that the US helped bankroll the supposed COVID lab leak.
In this segment of a remarkable interview by Megyn Kelly, Director of National Intelligence Tulsi Gabbard discusses the current Intelligence Community (IC) research into the origin of the SARS-CoV-2 pandemic (aka, COVID-19).
Gabbard talks about the U.S. government funding of “gain-of-function” research, which is a soft sounding phrase to describe the weaponization of biological agents.
Gabbard notes the gain-of-function research taking place in the Wuhan lab was coordinated and funded by the United States government, and the IC is close to making a direct link between the research and the release of the COVID-19 virus.
Additionally, Gabbard explains the concern of other biolabs around the world and then gets very close to the line of admitting the IC itself is politically weaponized (which it is but would be stunning to admit).
COVID-19
Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

From LifeSiteNews
A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna
A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.
The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:
Study Overview
- Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
- Intervention: Two doses of either:
- BNT162b2 (Pfizer-BioNTech)
- mRNA-1273 (Moderna)
- Follow-up Duration: 12 months after second dose.
- Comparison: Head-to-head between Pfizer vs. Moderna recipients.
- Main Outcomes:
- All-cause mortality
- Cardiovascular mortality
- COVID-19 mortality
- Non-COVID-19 mortality
All-cause mortality
Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.
- Pfizer Risk: 847.2 deaths per 100,000 people
- Moderna Risk: 617.9 deaths per 100,000 people
- Risk Difference:
➔ +229.2 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.37 (i.e., 37% higher mortality risk with Pfizer) - Odds Ratio (Adjusted):
➔ 1.384 (95% CI: 1.331–1.439)
Cardiovascular mortality
Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.
- Pfizer Risk: 248.7 deaths per 100,000 people
- Moderna Risk: 162.4 deaths per 100,000 people
- Risk Difference:
➔ +86.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.53 (i.e., 53% higher cardiovascular mortality risk) - Odds Ratio (Adjusted):
➔ 1.540 (95% CI: 1.431–1.657)
COVID-19 mortality
Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.
- Pfizer Risk: 55.5 deaths per 100,000 people
- Moderna Risk: 29.5 deaths per 100,000 people
- Risk Difference:
➔ +26.0 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.88 (i.e., 88% higher COVID-19 mortality risk) - Odds Ratio (Adjusted):
➔ 1.882 (95% CI: 1.596–2.220)
Non-COVID-19 mortality
Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.
- Pfizer Risk: 791.6 deaths per 100,000 people
- Moderna Risk: 588.4 deaths per 100,000 people
- Risk Difference:
➔ +203.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.35 (i.e., 35% higher non-COVID mortality risk) - Odds Ratio (Adjusted):
➔ 1.356 (95% CI: 1.303–1.412)
Biological explanations
The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:
The paper hypothesizes differences between Pfizer and Moderna may be due to:
- Different lipid nanoparticle compositions
- Differences in manufacturing, biodistribution, or storage conditions
Final conclusion
Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.
Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.
As the authors conclude:
These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.
Epidemiologist and Foundation Administrator, McCullough Foundation
Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.
Reprinted with permission from Focal Points.
-
2025 Federal Election2 days ago
The Liberals torched their own agenda just to cling to power
-
Crime1 day ago
Canada Blocked DEA Request to Investigate Massive Toronto Carfentanil Seizure for Terror Links
-
COVID-1921 hours ago
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’
-
Business21 hours ago
Top Canadian bank ditches UN-backed ‘net zero’ climate goals it helped create
-
Business2 days ago
Trump says he expects ‘great relationship’ with Carney, who ‘hated’ him less than Poilievre
-
Alberta13 hours ago
Pierre Poilievre will run to represent Camrose, Stettler, Hanna, and Drumheller in Central Alberta by-election
-
2025 Federal Election14 hours ago
Mark Carney vows to ‘deepen’ Canada’s ties with the world, usher in ‘new economy’
-
Health13 hours ago
RFK Jr. orders placebo safety trials for all new vaccines in major policy decision